Researchers introduced the typical alteration of LS (MSH2) into Hela cells by CRISPR/Cas9 system, despite the MMR-defective phenotype being constructed, engineered cells failed to exhibit MSI-H cancer [97].Thus, it is necessary to identify novel deleterious mutations in LS. This evidence concerns the gene LIAS and cancer.